ARTICLE | Clinical News
Eperzan albiglutide regulatory update
January 27, 2014 8:00 AM UTC
EMA's CHMP issued a positive opinion recommending approval of an MAA for Eperzan albiglutide from GlaxoSmithKline to treat Type II diabetes. The recommendation covers use of albiglutide as monotherapy...